Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Induce XT™ Bone Graft in Foot and Ankle Fusion

NCT06662266 is registered in ClinicalTrials.gov with Red Rock Regeneration Inc. as lead sponsor.

NCT NCT06662266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Induce XT™ Bone Graft in Foot and Ankle Fusion
Lead sponsor
Red Rock Regeneration Inc.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
May 12, 2025
Completion date
November 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankle arthropathy, foot deformities, surgery